(TGTX) TG Therapeutics - Performance 111.2% in 12m
TGTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
34.57%
#13 in Peer-Group
Rel. Strength
94.64%
#408 in Stock-Universe
Total Return 12m
111.23%
#10 in Peer-Group
Total Return 5y
87.97%
#15 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 158 |
| P/E Forward | 28.7 |
| High / Low | USD |
|---|---|
| 52 Week High | 45.51 USD |
| 52 Week Low | 16.57 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 17.89 |
| Buy/Sell Signal +-5 | -0.35 |
| Support / Resistance | Levels |
|---|---|
| Support | 34.1, 29.9 |
| Resistance | 43.0, 39.1, 36.9 |
12m Total Return: TGTX (111.2%) vs XBI (-9.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.46% | 73.5% | 70.3% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.04% | -3.43% | 142% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
5.15% | -1.28% | 42% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
0.49% | 32.6% | 2.32% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| PTCT NASDAQ PTC Therapeutics |
8.28% | 43.6% | -0.35% | 7.86 | 6.36 | 0.81 | - | 68% |
| NBIX NASDAQ Neurocrine Biosciences |
1.68% | -7.69% | -3.07% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
4.69% | 42.1% | -15.8% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.52% | 17.9% | 10.5% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: TGTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TGTX
| Total Return (including Dividends) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.06% | 2.99% | 0.45% |
| 3 Months | -14.76% | -7.01% | 5.67% |
| 12 Months | 111.23% | -9.24% | 10.61% |
| 5 Years | 87.97% | -24.27% | 107.31% |
| Trend Score (consistency of price movement) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 59.9% | 75.2% | 79.9% |
| 3 Months | -47.7% | 10% | 74.7% |
| 12 Months | 90.6% | -79% | 43.2% |
| 5 Years | -10.5% | -53.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #107 | -2.84% | -0.39% |
| 3 Month | #124 | -8.34% | -19.34% |
| 12 Month | #9 | 132.72% | 90.97% |
| 5 Years | #14 | 148.20% | -9.33% |
FAQs
Does TG Therapeutics (TGTX) outperform the market?
Yes,
over the last 12 months TGTX made 111.23%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.24%.
Over the last 3 months TGTX made -14.76%, while XBI made -7.01%.
Performance Comparison TGTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TGTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -10.3% | -0.4% | 4.8% | 101% |
| US NASDAQ 100 | QQQ | -10.3% | -1.3% | 5.2% | 101% |
| German DAX 40 | DAX | -8.9% | 2.2% | -11% | 82% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -11.2% | 0.4% | 4.6% | 100% |
| Hongkong Hang Seng | HSI | -10.9% | -4.7% | -14.1% | 83% |
| India NIFTY 50 | INDA | -8.7% | 1.8% | 5.6% | 113% |
| Brasil Bovespa | EWZ | -14.5% | -1.6% | -15.1% | 100% |
TGTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -10% | -1.5% | 0.9% | 88% |
| Consumer Discretionary | XLY | -8.4% | 3.2% | 16% | 94% |
| Consumer Staples | XLP | -9.7% | 2.2% | 4.1% | 105% |
| Energy | XLE | -15.5% | -5% | 0.2% | 107% |
| Financial | XLF | -9.6% | 2.7% | 1.1% | 87% |
| Health Care | XLV | -9.6% | 0.7% | 7.6% | 118% |
| Industrial | XLI | -10.1% | 1.3% | -1.2% | 93% |
| Materials | XLB | -9.4% | 0.1% | 4.1% | 112% |
| Real Estate | XLRE | -10.1% | 0.9% | 4.1% | 98% |
| Technology | XLK | -11.4% | -2.8% | 3.4% | 106% |
| Utilities | XLU | -10.6% | 2.7% | -2.1% | 92% |
| Aerospace & Defense | XAR | -11.6% | -4.8% | -12.8% | 69% |
| Biotech | XBI | -7.5% | -2.9% | 17.5% | 120% |
| Homebuilder | XHB | -6.2% | 6.7% | 20.6% | 122% |
| Retail | XRT | -7.8% | 0.1% | 11.3% | 109% |
TGTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -26.2% | -20.1% | -8.02% | 105% |
| Natural Gas | UNG | -20.7% | -12.3% | -17.3% | 119% |
| Gold | GLD | -13% | -4.6% | -23.6% | 66% |
| Silver | SLV | -12.8% | -14.6% | -17.1% | 86% |
| Copper | CPER | -8.8% | -2.9% | -11.5% | 102% |
TGTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -12% | -0.8% | 6.8% | 115% |
| iShares High Yield Corp. Bond | HYG | -11.1% | -0.5% | 1.3% | 102% |